Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
What's up in Oncology?
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5934236"]Genentech may be a sign of what’s to come. Oncology products are overpriced and our industry is under a lot of a scrutiny. We can’t afford to continue paying four reps to do one experienced reps job. Significant cost reduction with little/no negative impact to business.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5934236"]Genentech may be a sign of what’s to come. Oncology products are overpriced and our industry is under a lot of a scrutiny. We can’t afford to continue paying four reps to do one experienced reps job. Significant cost reduction with little/no negative impact to business.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
What's up in Oncology?
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
What's up in Oncology?
>